美国自愿性工作场所健康计划中的基因组检测：证据与挑战。
Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges.
机构信息
Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.
Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, Michigan, USA.
出版信息
Mol Genet Genomic Med. 2023 Nov;11(11):e2245. doi: 10.1002/mgg3.2245. Epub 2023 Aug 17.
BACKGROUND
Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included.
METHODS
Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives.
RESULTS
In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees.
CONCLUSION
Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging.
背景
工作场所基因和/或基因组检测（wGT）是雇主在自愿工作场所健康计划范围内可以提供的众多选择之一，但我们对有多少雇主提供这种福利，或者包括哪些类型的检测知之甚少。
方法
我们的景观调查旨在通过三种方法发现美国公司自愿健康计划中 wGT 的流行程度和分布：（1）分析公开可用信息；（2）全国性调查；（3）与公司代表的访谈。
结果
总共，我们调查的 420 家公司中有 50 家（11.9%）有公开数据表明他们向员工提供 wGT。加权以代表美国公司的类型和分布的调查数据表明，约有 1%的美国公司向其员工提供 wGT。
结论
我们的研究发现，尽管信息收集具有挑战性，但 wGT 在 美国公司中的广泛采用的证据很少。
Zotero 插件